MXPA05008690A - Derivados de adamantano, procedimientos para su preparacion y composiciones farmaceuticas que los contienen. - Google Patents
Derivados de adamantano, procedimientos para su preparacion y composiciones farmaceuticas que los contienen.Info
- Publication number
- MXPA05008690A MXPA05008690A MXPA05008690A MXPA05008690A MXPA05008690A MX PA05008690 A MXPA05008690 A MX PA05008690A MX PA05008690 A MXPA05008690 A MX PA05008690A MX PA05008690 A MXPA05008690 A MX PA05008690A MX PA05008690 A MXPA05008690 A MX PA05008690A
- Authority
- MX
- Mexico
- Prior art keywords
- processes
- preparation
- pharmaceutical composition
- composition containing
- adamantane derivatives
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- ORILYTVJVMAKLC-UHFFFAOYSA-N adamantane Chemical class C1C(C2)CC3CC1CC2C3 ORILYTVJVMAKLC-UHFFFAOYSA-N 0.000 title 1
- 229940052761 dopaminergic adamantane derivative Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C13/00—Cyclic hydrocarbons containing rings other than, or in addition to, six-membered aromatic rings
- C07C13/28—Polycyclic hydrocarbons or acyclic hydrocarbon derivatives thereof
- C07C13/32—Polycyclic hydrocarbons or acyclic hydrocarbon derivatives thereof with condensed rings
- C07C13/54—Polycyclic hydrocarbons or acyclic hydrocarbon derivatives thereof with condensed rings with three condensed rings
- C07C13/605—Polycyclic hydrocarbons or acyclic hydrocarbon derivatives thereof with condensed rings with three condensed rings with a bridged ring system
- C07C13/615—Polycyclic hydrocarbons or acyclic hydrocarbon derivatives thereof with condensed rings with three condensed rings with a bridged ring system with an adamantane ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
- C07C237/30—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to hydrogen atoms or to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/58—Ring systems containing bridged rings containing three rings
- C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
- C07C2603/74—Adamantanes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0300480A SE0300480D0 (sv) | 2003-02-21 | 2003-02-21 | Novel compounds |
| PCT/SE2004/000227 WO2004074224A1 (en) | 2003-02-21 | 2004-02-19 | Adamantane derivatives, processes for their preparation and pharmaceutical composition containing them |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA05008690A true MXPA05008690A (es) | 2005-10-05 |
Family
ID=20290476
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA05008690A MXPA05008690A (es) | 2003-02-21 | 2004-02-19 | Derivados de adamantano, procedimientos para su preparacion y composiciones farmaceuticas que los contienen. |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US7227038B2 (enExample) |
| EP (1) | EP1599432A1 (enExample) |
| JP (1) | JP2006518376A (enExample) |
| KR (1) | KR20050101559A (enExample) |
| CN (1) | CN100378047C (enExample) |
| AU (1) | AU2004213356B2 (enExample) |
| BR (1) | BRPI0407734A (enExample) |
| CA (1) | CA2515434A1 (enExample) |
| CO (1) | CO5580815A2 (enExample) |
| IL (1) | IL169818A0 (enExample) |
| IS (1) | IS8024A (enExample) |
| MX (1) | MXPA05008690A (enExample) |
| NO (1) | NO20054329L (enExample) |
| PL (1) | PL378574A1 (enExample) |
| RU (1) | RU2005123802A (enExample) |
| SE (1) | SE0300480D0 (enExample) |
| WO (1) | WO2004074224A1 (enExample) |
| ZA (1) | ZA200506579B (enExample) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI258462B (en) * | 1999-12-17 | 2006-07-21 | Astrazeneca Ab | Adamantane derivative compounds, process for preparing the same and pharmaceutical composition comprising the same |
| SE0200920D0 (sv) * | 2002-03-25 | 2002-03-25 | Astrazeneca Ab | Novel compounds |
| WO2004105797A1 (en) * | 2003-05-29 | 2004-12-09 | Astrazeneca Ab | A pharmaceutical composition comprising a p2x7 antagonist and sulfasalazine |
| KR20060037258A (ko) * | 2003-05-29 | 2006-05-03 | 아스트라제네카 아베 | Ｐ2Ｘ7-수용체 길항제 및 종양 괴사 인자 α를 포함하는제약 조성물 |
| WO2004105796A1 (en) * | 2003-05-29 | 2004-12-09 | Astrazeneca Ab | A pharmaceutical composition containing a p2x7 receptor antagonist and methotrexate |
| SE0302192D0 (sv) * | 2003-08-08 | 2003-08-08 | Astrazeneca Ab | Novel compounds |
| US8916546B2 (en) | 2003-08-29 | 2014-12-23 | Therapeutic Research Llc | Materials and methods for treatment and diagnosis of disorders associated with oxidative stress |
| SE0302488D0 (sv) * | 2003-09-18 | 2003-09-18 | Astrazeneca Ab | New combination |
| UA83881C2 (en) | 2003-12-18 | 2008-08-26 | Янссен Фармацевтика Н.В. | Pyrido- and pyrimidopyrimidine derivatives as anti-proliferative agents |
| GB0403864D0 (en) | 2004-02-20 | 2004-03-24 | Ucl Ventures | Modulator |
| SA05260265A (ar) * | 2004-08-30 | 2005-12-03 | استرازينيكا ايه بي | مركبات جديدة |
| SE0402925D0 (sv) * | 2004-11-30 | 2004-11-30 | Astrazeneca Ab | Novel Compounds |
| NI200700147A (es) | 2004-12-08 | 2019-05-10 | Janssen Pharmaceutica Nv | Derivados de quinazolina inhibidores de cinasas dirigidos a multip |
| WO2006083214A1 (en) * | 2005-02-02 | 2006-08-10 | Astrazeneca Ab | Pharmaceutical composition comprising a p2x7 receptor antagonist and a hmg-coa reductase inhibitor |
| US20080207577A1 (en) * | 2005-07-11 | 2008-08-28 | Astrazeneca Ab | Combination I |
| WO2007008157A1 (en) * | 2005-07-11 | 2007-01-18 | Astrazeneca Ab | New combination 2 |
| EA014779B1 (ru) | 2006-07-13 | 2011-02-28 | Янссен Фармацевтика Н.В. | Производные хиназолина в качестве mtki |
| TW200819416A (en) * | 2006-09-05 | 2008-05-01 | Astrazeneca Ab | Novel process 470 |
| CA2693715C (en) | 2007-07-27 | 2015-10-27 | Janssen Pharmaceutica Nv | Pyrrolopyrimidines |
| NZ587799A (en) | 2008-03-25 | 2012-06-29 | Affectis Pharmaceuticals Ag | Novel p2x7r antagonists and their use |
| KR20100053150A (ko) * | 2008-11-12 | 2010-05-20 | 한국생명공학연구원 | 아릴옥시아세틸계 유도체를 유효성분으로 포함하는 ｄｎａ 메틸트렌스퍼레이즈 억제용 약학적 조성물 |
| BRPI1014902A2 (pt) | 2009-04-14 | 2016-04-19 | Affectis Pharmaceuticals Ag | composto antagonista de p2x7r, sua composição e seus usos |
| MX2012013075A (es) | 2010-05-14 | 2012-12-17 | Affectis Pharmaceuticals Ag | Metodos novedosos para preparacion de antagonistas p2x7r. |
| WO2012110190A1 (en) | 2011-02-17 | 2012-08-23 | Affectis Pharmaceuticals Ag | Novel p2x7r antagonists and their use |
| WO2012163792A1 (en) | 2011-05-27 | 2012-12-06 | Affectis Pharmaceuticals Ag | Novel p2x7r antagonists and their use |
| WO2012163456A1 (en) | 2011-05-27 | 2012-12-06 | Affectis Pharmaceuticals Ag | Novel p2x7r antagonists and their use |
| RU2014106611A (ru) | 2011-07-22 | 2015-08-27 | Актелион Фармасьютиклз Лтд | Производные гетероциклических амидов в качестве антагонистов р2х7 рецептора |
| NZ628910A (en) | 2012-01-20 | 2016-02-26 | Actelion Pharmaceuticals Ltd | Heterocyclic amide derivatives as p2x7 receptor antagonists |
| CA2891090A1 (en) * | 2012-11-09 | 2014-05-15 | Scidose, Llc | Enema composition for treatment of ulcerative colitis having long term stability |
| PL2931717T3 (pl) | 2012-12-12 | 2017-05-31 | Actelion Pharmaceuticals Ltd. | Pochodne indolokarboksyamidu jako antagoniści receptora p2x7 |
| AR094053A1 (es) | 2012-12-18 | 2015-07-08 | Actelion Pharmaceuticals Ltd | Derivados de indol carboxamida como antagonistas del receptor p2x₇ |
| EP2956457B1 (en) | 2013-01-22 | 2016-11-23 | Actelion Pharmaceuticals Ltd | Heterocyclic amide derivatives as p2x7 receptor antagonists |
| ES2616114T3 (es) | 2013-01-22 | 2017-06-09 | Actelion Pharmaceuticals Ltd. | Derivados de amida heterocíclica como antagonistas del receptor P2X7 |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3352912A (en) | 1963-07-24 | 1967-11-14 | Du Pont | Adamantanes and tricyclo[4. 3. 1. 1 3.8] undecanes |
| US3471491A (en) | 1967-08-28 | 1969-10-07 | Squibb & Sons Inc | Adamantyl-s-triazines |
| US3464998A (en) | 1968-03-04 | 1969-09-02 | Searle & Co | Adamantyl esters and amides of pyridinecarboxylic acids |
| GB1274652A (en) | 1968-08-27 | 1972-05-17 | Lilly Industries Ltd | Adamantanyl-alkylamine derivatives and their preparation |
| IL53441A0 (en) | 1977-11-22 | 1978-01-31 | Teva Pharma | Methyladamantyl hydrazines their preparation and pharmaceutical compositions containing them |
| US4349552A (en) | 1978-10-30 | 1982-09-14 | Fujisawa Pharmaceutical Company, Ltd. | 5-Fluorouracil derivatives, and their pharmaceutical compositions |
| US4751292A (en) | 1985-07-02 | 1988-06-14 | The Plant Cell Research Institute, Inc. | Adamantyl purines |
| AU682051B2 (en) | 1993-08-10 | 1997-09-18 | James Black Foundation Limited | Gastrin and CCK receptor ligands |
| FR2761358B1 (fr) | 1997-03-27 | 1999-05-07 | Adir | Nouveaux composes de n-aryl piperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| ZA988967B (en) | 1997-10-03 | 2000-04-03 | Du Pont Pharm Co | Lactam metalloprotease inhibitors. |
| SE9704544D0 (sv) | 1997-12-05 | 1997-12-05 | Astra Pharma Prod | Novel compounds |
| SE9704545D0 (sv) | 1997-12-05 | 1997-12-05 | Astra Pharma Prod | Novel compounds |
| WO2000061569A1 (en) | 1999-04-09 | 2000-10-19 | Astrazeneca Ab | Adamantane derivatives |
| SE9904505D0 (sv) | 1999-12-09 | 1999-12-09 | Astra Pharma Prod | Novel compounds |
| TWI258462B (en) * | 1999-12-17 | 2006-07-21 | Astrazeneca Ab | Adamantane derivative compounds, process for preparing the same and pharmaceutical composition comprising the same |
| GB0013737D0 (en) | 2000-06-07 | 2000-07-26 | Astrazeneca Ab | Novel compounds |
| CA2447475A1 (en) | 2001-05-25 | 2002-12-05 | Chu-Biao Xue | Hydantion derivatives as inhibitors of matrix metalloproteinases |
| KR100908468B1 (ko) | 2001-07-02 | 2009-07-21 | 엔.브이.오가논 | 테트라히드로퀴놀린 유도체 |
| PA8557501A1 (es) | 2001-11-12 | 2003-06-30 | Pfizer Prod Inc | Benzamida, heteroarilamida y amidas inversas |
| WO2003042190A1 (en) | 2001-11-12 | 2003-05-22 | Pfizer Products Inc. | N-alkyl-adamantyl derivatives as p2x7-receptor antagonists |
| SE0103836D0 (sv) * | 2001-11-16 | 2001-11-16 | Astrazeneca Ab | Novel compounds |
| SE0200920D0 (sv) | 2002-03-25 | 2002-03-25 | Astrazeneca Ab | Novel compounds |
| SE0300445D0 (sv) | 2003-02-18 | 2003-02-18 | Astrazeneca Ab | New combination |
| WO2004105796A1 (en) | 2003-05-29 | 2004-12-09 | Astrazeneca Ab | A pharmaceutical composition containing a p2x7 receptor antagonist and methotrexate |
| WO2004105797A1 (en) | 2003-05-29 | 2004-12-09 | Astrazeneca Ab | A pharmaceutical composition comprising a p2x7 antagonist and sulfasalazine |
| KR20060037258A (ko) | 2003-05-29 | 2006-05-03 | 아스트라제네카 아베 | Ｐ2Ｘ7-수용체 길항제 및 종양 괴사 인자 α를 포함하는제약 조성물 |
| SE0302192D0 (sv) | 2003-08-08 | 2003-08-08 | Astrazeneca Ab | Novel compounds |
| SE0302488D0 (sv) | 2003-09-18 | 2003-09-18 | Astrazeneca Ab | New combination |
-
2003
- 2003-02-21 SE SE0300480A patent/SE0300480D0/xx unknown
-
2004
- 2004-02-19 WO PCT/SE2004/000227 patent/WO2004074224A1/en not_active Ceased
- 2004-02-19 RU RU2005123802/04A patent/RU2005123802A/ru not_active Application Discontinuation
- 2004-02-19 AU AU2004213356A patent/AU2004213356B2/en not_active Ceased
- 2004-02-19 US US10/546,131 patent/US7227038B2/en not_active Expired - Fee Related
- 2004-02-19 BR BRPI0407734-2A patent/BRPI0407734A/pt not_active IP Right Cessation
- 2004-02-19 EP EP04712798A patent/EP1599432A1/en not_active Withdrawn
- 2004-02-19 JP JP2006502807A patent/JP2006518376A/ja not_active Withdrawn
- 2004-02-19 MX MXPA05008690A patent/MXPA05008690A/es unknown
- 2004-02-19 KR KR1020057015302A patent/KR20050101559A/ko not_active Withdrawn
- 2004-02-19 CN CNB2004800047676A patent/CN100378047C/zh not_active Expired - Fee Related
- 2004-02-19 PL PL378574A patent/PL378574A1/pl not_active Application Discontinuation
- 2004-02-19 CA CA002515434A patent/CA2515434A1/en not_active Abandoned
-
2005
- 2005-07-21 IL IL169818A patent/IL169818A0/en unknown
- 2005-08-02 CO CO05076011A patent/CO5580815A2/es not_active Application Discontinuation
- 2005-08-17 ZA ZA200506579A patent/ZA200506579B/en unknown
- 2005-09-14 IS IS8024A patent/IS8024A/is unknown
- 2005-09-20 NO NO20054329A patent/NO20054329L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PL378574A1 (pl) | 2006-05-02 |
| AU2004213356A1 (en) | 2004-09-02 |
| CO5580815A2 (es) | 2005-11-30 |
| IL169818A0 (en) | 2007-07-04 |
| US7227038B2 (en) | 2007-06-05 |
| CN1751010A (zh) | 2006-03-22 |
| KR20050101559A (ko) | 2005-10-24 |
| NO20054329D0 (no) | 2005-09-20 |
| JP2006518376A (ja) | 2006-08-10 |
| NO20054329L (no) | 2005-11-21 |
| CN100378047C (zh) | 2008-04-02 |
| SE0300480D0 (sv) | 2003-02-21 |
| RU2005123802A (ru) | 2006-02-27 |
| CA2515434A1 (en) | 2004-09-02 |
| BRPI0407734A (pt) | 2006-02-14 |
| IS8024A (is) | 2005-09-14 |
| EP1599432A1 (en) | 2005-11-30 |
| AU2004213356B2 (en) | 2007-03-15 |
| ZA200506579B (en) | 2006-05-31 |
| US20060160904A1 (en) | 2006-07-20 |
| WO2004074224A1 (en) | 2004-09-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA05008690A (es) | Derivados de adamantano, procedimientos para su preparacion y composiciones farmaceuticas que los contienen. | |
| SE0200920D0 (sv) | Novel compounds | |
| MY136430A (en) | N-adamantylmethyl derivatives, pharmaceutical compositions containing them and processes for their preparation | |
| SE0104140D0 (sv) | Novel Compounds | |
| SE0202539D0 (sv) | Compounds | |
| TW200508214A (en) | Novel compounds | |
| TW200613243A (en) | Novel compounds | |
| PL366198A1 (en) | Novel compounds | |
| DE602004021472D1 (en) | Pyrimiidinverbindungen | |
| ATE316083T1 (de) | Adamantanderivate | |
| SE9904505D0 (sv) | Novel compounds | |
| MY122392A (en) | Adamantane derivatives of use of p2x7 receptor antagonists, a process for their preparation, pharmaceutical compositions containing them and a process for preparing the pharmaceutical compositions | |
| AU2003228770A8 (en) | Substituted pyrazolopyrimidines | |
| TW200616995A (en) | Novel compounds | |
| TW200800999A (en) | Novel compounds | |
| SE0302192D0 (sv) | Novel compounds | |
| MY128924A (en) | Novel compounds | |
| TW200604197A (en) | New compounds | |
| SE0302139D0 (sv) | Novel compounds | |
| MX2009006010A (es) | Derivados de amina y su uso en enfermedades mediadas por el adrenoreceptor beta 2. | |
| GB0109122D0 (en) | Novel compounds | |
| TW200626553A (en) | Novel compounds | |
| TW200639156A (en) | New compounds | |
| SE0101038D0 (sv) | Novel compounds | |
| UA90285C2 (ru) | Производные гидантоина, полезные как ингибиторы металлопротеиназ |